5/12/2011 | HYLM | Talecris Biotherapeutics calls $60 million of 73/4% notes due 2016
|
1/25/2011 | HY | Market Commentary: Hertz drive-by, Dana two-parter lead nearly $2 billion primary; new deals move up; OPTI busy
|
7/21/2010 | BKHY | Moody's puts Talecris on review
|
7/20/2010 | BKHY | Moody's gives Grifols B1, loans Ba3, B3
|
6/9/2010 | HY | Market Commentary: Market awaits TransUnion, Michael Foods slates; recent new deals steady, energy slides again
|
6/7/2010 | BKHY | Moody's: Talecris outlook at developing
|
3/17/2010 | BKBWHY | Talecris' CEO says capital structure now supports long-term growth
|
10/19/2009 | HY | Market Commentary: Rite Aid, Terra, ViaSat price deals, new bonds firmer; CIT up after Icahn news; Tronox down
|
10/16/2009 | HY | New Issue: Talecris upsizes to $600 million, sells 73/4% seven-year notes at 99.321 to yield 7 7/8%
|
10/16/2009 | HY | Market Commentary: Trico, Talecris, Superior Plus deals price, Trico firms smartly; Sinclair up; Tronox tops out
|
10/15/2009 | HY | Market Commentary: Calpine, Sinclair, Drummond deals price, Reynolds slates; Tronox remains busy; funds gain $237 million
|
10/15/2009 | HY | Talecris Biotherapeutics talks $550 million seven-year notes at 8% area with 1-2 points OID
|
10/14/2009 | BKHY | Moody's raises Talecris, rates notes B1
|
10/13/2009 | BK | Talecris amends revolver, permitting notes sale for loan repayments
|
10/13/2009 | HY | Talecris to price $550 million seven-year senior notes this week
|
10/13/2009 | HY | Market Commentary: Alon prices, Calpine, Sinclair, others slate; new NOVA, Solutia up, also Tronox; CIT slides
|
9/15/2009 | BK | Talecris to pay down first-, second-lien bank debt with IPO proceeds
|